None listed
Conditions
Brief summary
To compare the outcome of daily intermittent intravenous dosing of ceftriaxone verses continuous intravenous infusion of cefazolin by looking at treatment duration in patients admitted with cellulitis to the CHQ at Home’s Hospital in the Home program from 1st of January 2020 to 30th of June 2024.
Interventions
To compare the outcome of daily intermittent intravenous dosing of ceftriaxone verses continuous intravenous infusion of cefazolin by looking at treatment duration in patients admitted with cellulitis to the Cildren's Health Queensland (CHQ) Home’s Hospital in the Home program from 1st of January 2020 to 30th of June 2024. The retrospective study involve individual chart review to determine the duration on IV antibiotics .
Sponsors
Queensland Children's Hospital
Eligibility
Sex/Gender
All
Age
3 Months to 17 Years
Healthy volunteers
No
Inclusion criteria
All children with a cellulitis diagnosis admitted to the CHQ at home HITH program between 1 January 2020 and 30 June 2024 were identified through the hospital informatic system. Only patients who received either ceftriaxone or cefazolin were included in audit.
Exclusion criteria
Children with underlying complex co-morbidities, such as immunodeficiency (including patients on chemotherapy, corticosteroids, or biologic agents) or significant renal or liver disease were excluded • Complex cellulitis (e.g., associated with vascular malformation, multiple concurrent soft tissue infections, infection secondary to an implanted device or cellulitis with complex abscess requiring surgical drainage in theatre) • Postoperative or radiotherapy complication • Diagnosed or suspicion of orbital cellulitis • Cellulitis secondary to infected varicella and HSV • Non cellulitis soft tissue infection
Outcome results
None listed